CytoDyn settles class action over director removal clause; pays $59,500

CytoDyn Inc.

Class action challenged 'Only With Cause Clause' for removing directors; court invalidated it in January 2022.
Company filed Certificate of Correction in April 2022 to remove the clause per court order.
Settlement reached in December 2023: $59,500 in attorneys' fees and expenses plus $500 service award to plaintiffs.
No admission of liability; court has not expressed opinion on fee amount.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.